Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DH 
Definitive Healthcare Corp (DH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/03/2025: DH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $4.06
1 Year Target Price $4.06
| 3 | Strong Buy |
| 0 | Buy |
| 9 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -55.75% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 275.83M USD | Price to earnings Ratio - | 1Y Target Price 4.06 |
Price to earnings Ratio - | 1Y Target Price 4.06 | ||
Volume (30-day avg) 14 | Beta 1.61 | 52 Weeks Range 2.15 - 5.68 | Updated Date 12/3/2025 |
52 Weeks Range 2.15 - 5.68 | Updated Date 12/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-06 | When - | Estimate 0.06 | Actual 0.07 |
Profitability
Profit Margin -77.88% | Operating Margin (TTM) -5.63% |
Management Effectiveness
Return on Assets (TTM) -0.87% | Return on Equity (TTM) -49.18% |
Valuation
Trailing PE - | Forward PE 10.52 | Enterprise Value 282859619 | Price to Sales(TTM) 1.14 |
Enterprise Value 282859619 | Price to Sales(TTM) 1.14 | ||
Enterprise Value to Revenue 1.17 | Enterprise Value to EBITDA 46.69 | Shares Outstanding 103303387 | Shares Floating 37584871 |
Shares Outstanding 103303387 | Shares Floating 37584871 | ||
Percent Insiders 9.42 | Percent Institutions 94.09 |
Upturn AI SWOT
Definitive Healthcare Corp
Company Overview
History and Background
Definitive Healthcare Corp was founded in 2011. It evolved from providing healthcare data to offering a comprehensive intelligence platform.
Core Business Areas
- Commercial Intelligence: Provides data and analytics on healthcare providers and their affiliations, enabling commercial teams to identify opportunities, track market trends, and improve sales effectiveness.
- Strategic Intelligence: Helps healthcare organizations and investors with strategic planning, market analysis, and due diligence through detailed data and insights.
Leadership and Structure
Robert Musslewhite is the CEO. The company has a typical corporate structure with departments for sales, marketing, product development, and finance.
Top Products and Market Share
Key Offerings
- Monocl ExpertConnect: Connects users with key opinion leaders and healthcare experts. No definitive market share data available, but a key product offering. Competitors include GLG and Guidepoint.
- Passport Analytics Suite: Provides comprehensive data and analytics on healthcare providers. Competitors include IQVIA and Veeva Systems. This product is used to analyze claims data, referral patterns, and market trends.
Market Dynamics
Industry Overview
The healthcare data and analytics market is growing, driven by the increasing need for data-driven decision-making in the healthcare industry.
Positioning
Definitive Healthcare is positioned as a leading provider of healthcare commercial intelligence, offering a comprehensive data platform and analytics tools.
Total Addressable Market (TAM)
The TAM is estimated to be in the billions of dollars. Definitive Healthcare is well-positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Comprehensive data platform
- Strong customer relationships
- Experienced management team
- Proprietary data and analytics
Weaknesses
- Reliance on data quality
- Potential for data breaches
- Limited international presence
- Integration risk with acquired companies
Opportunities
- Expanding product offerings
- Increasing demand for healthcare data
- Strategic acquisitions
- Entering new geographic markets
Threats
- Increased competition
- Changing healthcare regulations
- Economic downturn
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- IQVIA (IQV)
- Veeva Systems (VEEV)
- Health Catalyst (HCAT)
Competitive Landscape
Definitive Healthcare competes with a mix of large healthcare data providers and smaller niche players. Its comprehensive data platform and focus on commercial intelligence are key advantages.
Major Acquisitions
Trilliant Health
- Year: 2021
- Acquisition Price (USD millions): 375
- Strategic Rationale: Expanded Definitive Healthcare's data assets and analytics capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historically, Definitive Healthcare has experienced rapid growth driven by increasing demand for its data and analytics solutions.
Future Projections: Future growth is projected to be strong, driven by new product offerings, acquisitions, and market expansion.
Recent Initiatives: Recent initiatives include expanding its product suite, acquiring complementary businesses, and investing in its technology platform.
Summary
Definitive Healthcare is a strong player in the healthcare data and analytics market, benefiting from its comprehensive data platform and strong customer relationships. Its growth strategy involves expanding its product offerings and making strategic acquisitions. Potential challenges include increased competition and the need to maintain data quality and security. Its future growth is tied to adoption of data-driven decision-making in healthcare.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Definitive Healthcare Corp
Exchange NASDAQ | Headquaters Framingham, MA, United States | ||
IPO Launch date 2021-09-15 | CEO & Director Mr. Kevin D. Coop | ||
Sector Healthcare | Industry Health Information Services | Full time employees 782 | Website https://www.definitivehc.com |
Full time employees 782 | Website https://www.definitivehc.com | ||
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.